]>
IRCT20200428047229N1 IRCT 2020-06-27 Esfahan University of Medical Sciences Effect of Medical Beer on COVID-19 Investigating the effect of Medical Beer on the fever of patients with COVID-19 2020-03-29 anticipated 60 Complete https://irct.ir/trial/47530 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: At first due to the inclusion criteria, infectious diseases specialist diagnosis and positive PCR test, Patients will be selected and then randomly assigned to the experimental and control groups according to the random sequence obtained through random allocation software. 3 covid-19. Intervention 1: Intervention group: Patients in this group receive the treatment of COVID-19 according to the protocol of the Ministry of Health, in addition they should recieve daily a glass of medical bear (200 CC) every 4 hours for 5 days.This medicine has no chemical composition and is not made by any factory. This medicine is prepared from barley decoction according to the previous coordination with the hospital kitchen and is provided to the patients. Intervention 2: Control group: Patients in this group receive medication for COVID-19 according to the Ministry of Health protocol. Yes - There is a plan to make this available What will be shared: Publishing results in form of an article When: After completing the research work To whom: Public Conditions: for research reasons Where to obtain: Isfahan University of Medical Sciences How to obtain: approving by responsible officer Comments:
public Hanieh Tahermohammadi
Faculty of Traditional Medicine, Shams Alley, Tavanir Station, Valiasr St., Tehran Town
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 dr.hmohammadi@sbmu.ac.ir Shahid Beheshti University of Medical Sciences scientific Mojgan Tansaz
No.8 Shams Alley, opposite Street Tavanir, Vali Asr Street, Tehran
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 Tansaz_mojgan@yahoo.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Patients aged 18 to 70 years with inpatient clinical criteria (fever ≥ 38% or severe cough or shortness of breath or respiratory rate ≥ 24 per minute or oxygen saturation <93%) Positive PCR Lung involvement in CT scan of the chest 18 years 70 years Both Previous COVID-19 treatment Allergies and asthma High blood pressure Diabetes Pregnancy Breastfeeding Heart failure Chronic renal failure Get chemotherapy Get Corticostroids Immune deficiency Patient request Need to be admitted to the ICU U07.1 COVID-19, virus identified Treatment - Drugs Treatment - Drugs Intervention group: Patients in this group receive the treatment of COVID-19 according to the protocol of the Ministry of Health, in addition they should recieve daily a glass of medical bear (200 CC) every 4 hours for 5 days.This medicine has no chemical composition and is not made by any factory. This medicine is prepared from barley decoction according to the previous coordination with the hospital kitchen and is provided to the patients. Control group: Patients in this group receive medication for COVID-19 according to the Ministry of Health protocol. Fever. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: Mercury thermometer (oral). Muscular pain. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient and the Visual Analog Scale (VAS) score. Dry cough. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient. Dyspnea. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient. ESR. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Sed rate device. CRP. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Agglutination kit. Blood cell count. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Cell Counter device. Chest X-ray. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the medical beer. Method of measurement: Radiology set. Chest CT scan. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5, if requested by the treating physician, it will be recorded. Method of measurement: CT scan set. Esfahan University of Medical Sciences Approved 2020-04-27 Ethics Committee of Isfahan University of Medical Sciences Isfahan University of Medical Sciences, Hezarjerib street, Iran Isfahan Isfehan Iran (Islamic Republic of)